User profiles for CAROLINE J. DORÉ

Caroline Jane Dore

statistician
Verified email at ucl.ac.uk
Cited by 30932

SPIRIT 2013 statement: defining standard protocol items for clinical trials

…, H Mann, K Dickersin, JA Berlin, CJ Doré… - Annals of internal …, 2013 - acpjournals.org
The protocol of a clinical trial serves as the foundation for study planning, conduct, reporting,
and appraisal. However, trial protocols and existing protocol guidelines vary greatly in …

Shear-wave elastography improves the specificity of breast US: the BE1 multinational study of 939 masses

WA Berg, DO Cosgrove, CJ Doré, FKW Schäfer… - Radiology, 2012 - pubs.rsna.org
Purpose To determine whether adding shear-wave (SW) elastographic features could improve
accuracy of ultrasonographic (US) assessment of breast masses. Materials and Methods …

[HTML][HTML] Shear wave elastography for breast masses is highly reproducible

…, WA Berg, CJ Doré, DM Skyba, JP Henry, J Gay… - European …, 2012 - Springer
Objectives To evaluate intra- and interobserver reproducibility of shear wave elastography (SWE)
for breast masses. Methods For intraobserver reproducibility, each observer obtained …

Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study

EL Thomas, G Hamilton, N Patel, R O'dwyer, CJ Doré… - Gut, 2005 - gut.bmj.com
Background: Hepatic steatosis is associated with obesity and type II diabetes. Proton magnetic
resonance spectroscopy ( 1 H MRS) is a non-invasive method for measurement of tissue …

[HTML][HTML] Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised …

…, M Ruiz-Castellano, N Muirhead, CJ Doré… - The Lancet …, 2016 - thelancet.com
Background Rivaroxaban is established for the treatment and secondary prevention of venous
thromboembolism, but whether it is useful in patients with antiphospholipid syndrome is …

[HTML][HTML] The risks and rewards of covariate adjustment in randomized trials: an assessment of 12 outcomes from 8 studies

BC Kahan, V Jairath, CJ Doré, TP Morris - Trials, 2014 - Springer
Background Adjustment for prognostic covariates can lead to increased power in the analysis
of randomized trials. However, adjusted analyses are not often performed in practice. …

[HTML][HTML] Asymptomatic internal carotid artery stenosis and cerebrovascular risk stratification

…, G Geroulakos, N Labropoulos, CJ Doré… - Journal of vascular …, 2010 - Elsevier
BACKGROUND: The purpose of this study was to determine the cerebrovascular risk
stratification potential of baseline degree of stenosis, clinical features, and ultrasonic plaque …

Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days

A Jindani, CJ Doré, DA Mitchison - American journal of respiratory …, 2003 - atsjournals.org
Colony-forming units of Mycobacterium tuberculosis in sputum were counted at 2-day intervals
in 100 patients treated with 22 regimens of isoniazid, rifampin, pyrazinamide, ethambutol, …

[HTML][HTML] Altered adiposity after extremely preterm birth

S Uthaya, EL Thomas, G Hamilton, CJ Doré, J Bell… - Pediatric …, 2005 - nature.com
The quantity and distribution of adipose tissue are markers of morbidity risk. The third trimester
of human development is a period of rapid adipose tissue deposition. Preterm infants may …

A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism

…, PJ Lumb, DB Freedman, M Crook, CJ Doré… - The American journal of …, 2002 - Elsevier
PURPOSE: The role of thyroxine replacement in subclinical hypothyroidism remains unclear.
We performed a 6-month randomized, double-blind, placebo-controlled trial to evaluate the …